Dermatology

Top Story

FDA approves Baxdela for treatment of ABSSSIs

June 20, 2017

The FDA recently approved an IV and oral formulation of Baxdela, an anionic fluoroquinolone, for the treatment of acute bacterial skin and skin structure infections, or ABSSSIs, including MRSA.

The approval of both formulations is supported by data from two phase 3 trials that showed Baxdela (delafloxacin, Melinta Therapeutics) had similar safety and efficacy profiles against ABSSSIs compared with a combination regimen of vancomycin and aztreonam, according to a press release from the manufacturer.

In the Journals

Children at risk for podoconiosis report inaccurate risk factors

June 12, 2017
Although podoconiosis — otherwise known as nonfilarial elephantiasis, or ”mossy foot” — is a common and preventable disease in areas of Ethiopia…
Meeting News

Taksta noninferior to Zyvox in treating ABSSSIs, including MRSA

June 4, 2017
NEW ORLEANS — Taksta was noninferior to Zyvox as an oral treatment for acute bacterial skin and skin structure infections, or ABSSSIs, including MRSA, according to…
Meeting News

Baxdela well-tolerated, effective against ABSSSIs

June 3, 2017
NEW ORLEANS — Data from two phase 3 trials demonstrated that IV and oral Baxdela had similar safety and efficacy profiles against acute bacterial skin and skin…
CME CE CNE CPE CPE

HIV/AIDS 1 Hour Update For Florida Health Professionals

No commercial support for this activity.

This is a 1 hour activity designed for home study by healthcare clinicians. Specifically, it meets the 1 hour HIV/AIDS…
More »
In the Journals

Children at risk for podoconiosis report inaccurate risk factors

June 12, 2017
Although podoconiosis — otherwise known as nonfilarial elephantiasis, or ”mossy foot” — is a…
More »
Resource Centers
ASM Microbe

ASM Microbe

Video
Meeting News Coverage

VIDEO: Recent advances made in leishmaniasis vaccine development

October 27, 2015
More »
FDA News

FDA approves Baxdela for treatment of ABSSSIs

June 20, 2017
The FDA recently approved an IV and oral formulation of Baxdela, an anionic fluoroquinolone, for the treatment of acute bacterial skin and skin…

In the Journals

Children at risk for podoconiosis report inaccurate risk factors

June 12, 2017
Although podoconiosis — otherwise known as nonfilarial elephantiasis, or ”mossy foot” — is a common and preventable disease…

Meeting News

Taksta noninferior to Zyvox in treating ABSSSIs, including MRSA

June 4, 2017
NEW ORLEANS — Taksta was noninferior to Zyvox as an oral treatment for acute bacterial skin and skin structure infections, or ABSSSIs…

Meeting News

Baxdela well-tolerated, effective against ABSSSIs

June 3, 2017
NEW ORLEANS — Data from two phase 3 trials demonstrated that IV and oral Baxdela had similar safety and efficacy profiles against acute…

In the Journals

Dermatologists infrequently diagnose syphilis

May 9, 2017
Although the incidence of syphilis has been rising in the United States, dermatologists may infrequently diagnose the disease, according to a…

Meeting News

Omadacycline noninferior to Zyvox in treating ABSSSIs, including MRSA

April 28, 2017
Treatment of skin infections with the antibiotic omadacycline was noninferior to Zyvox in a phase 3 study, researchers said at the European Congress…

Meeting News

Analyses show cost savings of omadacycline for ABSSSI

April 25, 2017
Two cost-benefit analyses presented at the annual meeting of the European Congress of Clinical Microbiology and Infectious Diseases in Vienna…

Climate change brings new infectious disease threats

April 22, 2017
Climate change is expected to increase the risk for the spread of numerous types of infectious diseases — including Lyme disease, Zika…

A model of success: The VA’s battle against MRSA

April 18, 2017
The growing problem of antibiotic resistance threatens the successful prevention and treatment of an increasing range of infections. This mounting…

In the Journals Plus

Etiology of SSSIs similar in patients with, without diabetes

April 13, 2017
Patients with diabetes had microbiological etiologies in complicated skin and skin structure infections similar to that of patients without

More Headlines »
Advertisement
Advertisement